Dehydroepiandrosterone, DHEA

Dehydroepiandrosterone is a natural sexual hormone made from cholesterol that promotes testosterone and estrogen synthesis. Natural DHEA levels peak in early adulthood and then slowly fall with aging, like most sexual hormones. Synthetic DHEA is sold as a supplement, as a tablet, and topical cream. It is often used as an anti-aging therapy, and also claimed to prevent chronic diseases and improve physical performance.

  • Origin: Synthetic, Nonessential
  • Source: Nonessential, Synthetic
  • Type: Hormone/Hormone Precursor
  • Age Range: Adults, Seniors
  • Toxicity: May be toxic in high doses
  • Outcomes: Men’s Health, Women’s Health, Testosterone, Prevention of Ovular Aging

What are DHEA benefits?

Produced in our bodies from other fatty acids, DHEA has many benefits for our bodies. Besides reducing the risk of heart disease, DHA can improve ADHD, fight inflammation, aid muscle recovery, and improve eye health. DHEA is present in oily fish, as is omega-3. Because of our body’s low DHEA production, we need to consume this nutraceutical daily to notice the expected benefits. Check out our 3-step test to see which nutraceuticals can help you, as well as DHEA!

Table of relations

Outcome
Sub-Outcome
Consistent effects
Strength of effects
Scientific articles
Men’s Health Men’s Health
Testosterone
See All 6 studies
Women’s Health Women’s Health
Prevention of Ovular Aging
See All 3 studies

Men's Health DHEA and Men's Health

A man's health is the result of various habits throughout his life, such as diet, exercise, vaccinations, routine exams, and family history. Male health has biological differences from female health, such as: hormone levels, sexual life and libido, and the cognitive system. Keeping your body healthy requires discipline and attention to monitoring, because these differences require specific care and solutions for a balanced body. Nutraceuticals can help all areas of man's health to function in harmony, from the extraction of vitamins, minerals, and other substances from nature's plants, fruits, and herbs, they boost the good performance of every part of the body.

  • Testosterone

    Testosterone is the main male sex hormone. It is responsible for regulating fertility, muscle mass, fat distribution and the production of red blood cells. Women's ovaries also produce testosterone, although in much smaller quantities.

Women's Health DHEA and Women's Health

The female body has specific physiological processes involving sex hormones, health of the ovaries, uterus and vagina, menstrual cycle, pregnancy and lactation and menopause. The compounds indicated for women's health assist in the synthesis and secretion of these hormones, in premenstrual and menopausal symptoms and in the protection of female sexual organs.

  • Prevention of Ovular Aging

    A very common problem in women's fertility is the average age at which they wish to become pregnant. Because of this high, the prevention of ovarian aging has become an important issue, because few women pay attention to this, causing difficulties in future conception. The good news is that this aging can be postponed through supplementation or medication, and thus it is worth choosing the healthiest and most affordable option as a way to invest in your health and preserve your plans for tomorrow. Supplementation is extracted from common foods, taking vitamins, minerals, and other substances and making them easily accessible to all who wish to consume and preserve their ovaries.

Table of negative interactions

Drugs
Carfilzomib, Leflunomide, Lomitapide, Mipomersen, Pexidartinib, Teriflunomide

Related videos about DHEA

Other Hormone/Hormone Precursor

Melatonin

Energy and Mood Gut Health Women's Health

Melatonin is a hormone naturally produced by the pineal gland and it’s primary function is to induce sleep and regulate sleep patterns. Vario...

Ver mais

References

  1. ^ Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA. (1998)
  2. ^ a b c Omura Y. Beneficial effects and side effects of DHEA: true anti-aging and age-promoting effects, as well as anti-cancer and cancer-promoting effects of DHEA evaluated from the effects on the normal and cancer cell telomeres and other parameters. Acupunct Electrother Res. (2005)
  3. ^ a b c Orentreich N, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. (1984)
  4. ^ a b c Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. (2011)
  5. ^ a b c d e f g h i j k Traish AM, et al. Dehydroepiandrosterone (DHEA)–a precursor steroid or an active hormone in human physiology. J Sex Med. (2011)
  6. ^ a b Chung BC, et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci U S A. (1987)
  7. ^ Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. (2010)
  8. ^ Patel SS, et al. 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary. Reprod Sci. (2010)
  9. ^ Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids.
  10. ^ Fitzpatrick JL, et al. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions. Arch Biochem Biophys. (2001)
  11. ^ a b Le Mée S, et al. 7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes. Steroids. (2008)
  12. ^ Morfin R, Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Mol Biol. (1994)
  13. ^ El Kihel L. Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)–recent reports. Steroids. (2012)
  14. ^ Robinzon B, Prough RA. Interactions between dehydroepiandrosterone and glucocorticoid metabolism in pig kidney: nuclear and microsomal 11beta-hydroxysteroid dehydrogenases. Arch Biochem Biophys. (2005)
  15. ^ Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11β-hydroxysteroid dehydrogenases?.
  16. ^ a b Labrie F, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol. (2006)
  17. ^ a b Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem. (2002)
  18. ^ a b c d Liu D, et al. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology. (2007)
  19. ^ a b c d Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids. (2004)
  20. ^ a b c Martina V, et al. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Clin Endocrinol (Oxf). (2006)
  21. ^ a b Liu D, et al. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology. (2008)
  22. ^ Radford DJ, et al. Dehdyroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. Mol Endocrinol. (2010)
  23. ^ Hennebert O, et al. Anti-inflammatory effects and changes in prostaglandin patterns induced by 7beta-hydroxy-epiandrosterone in rats with colitis. J Steroid Biochem Mol Biol. (2008)
  24. ^ Chen F, et al. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology. (2005)
  25. ^ Sandra N, et al. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines. Steroids. (2012)
  26. ^ a b Orentreich N, et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. (1992)
  27. ^ Bélanger A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab. (1994)
  28. ^ Ponholzer A, et al. Association of DHEA-S and estradiol serum levels to symptoms of aging men. Aging Male. (2002)
  29. ^ a b c Arlt W, et al. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab. (2001)
  30. ^ a b c d e f g Labrie F, et al. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. J Steroid Biochem Mol Biol. (2007)
  31. ^ a b c Labrie F, et al. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol. (2008)
  32. ^ Bélanger A, et al. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab. (2003)
  33. ^ Hum DW, et al. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol. (1999)
  34. ^ Turgeon D, et al. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. (2001)
  35. ^ Labrie F, et al. Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol. (2007)
  36. ^ a b c d Acacio BD, et al. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men. Fertil Steril. (2004)
  37. ^ Auci DL, et al. A potential role for 5-androstene-3β,7β,17β-triol in obesity and metabolic syndrome. Obesity (Silver Spring). (2011)
  38. ^ Thaler LM, Blevins LS Jr. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab. (1998)
  39. ^ a b Hucklebridge F, et al. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology. (2005)
  40. ^ Granger DA, et al. Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology. (1999)
  41. ^ Oskis A, et al. Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescents. Stress. (2012)
  42. ^ Ahn RS, et al. Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levels. Yonsei Med J. (2007)
  43. ^ Matchock RL, Dorn LD, Susman EJ. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls during puberty. Chronobiol Int. (2007)
  44. ^ Markopoulou K, et al. The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology. (2009)
  45. ^ Young AH, Gallagher P, Porter RJ. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry. (2002)
  46. ^ Michael A, et al. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry. (2000)
  47. ^ Lawson EA, et al. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab. (2009)
  48. ^ a b Gallagher P, et al. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr Res. (2007)
  49. ^ Ritsner M, et al. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol. (2004)
  50. ^ Strous RD, et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry. (2003)
  51. ^ Nachshoni T, et al. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Schizophr Res. (2005)
  52. ^ Ritsner MS, et al. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial. J Clin Psychopharmacol. (2006)
  53. ^ Cleare AJ, O’Keane V, Miell JP. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology. (2004)
  54. ^ Ritsner M, et al. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology. (2005)
  55. ^ Pawlikowski M, et al. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett. (2002)
  56. ^ Miodownik C, et al. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients. Clin Neuropharmacol. (2011)
  57. ^ Liu TC, et al. Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. Eur J Appl Physiol. (2013)
  58. ^ Komesaroff PA. Unravelling the enigma of dehydroepiandrosterone: moving forward step by step. Endocrinology. (2008)
  59. ^ Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen.
  60. ^ Kurzman ID, et al. The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: a clinical trial. Obes Res. (1998)
  61. ^ Marder W, et al. Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study. Lupus. (2010)
  62. ^ a b Jankowski CM, et al. Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids. Clin Endocrinol (Oxf). (2011)
  63. ^ a b c Barnhart KT, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab. (1999)
  64. ^ a b c Jedrzejuk D, et al. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism. Aging Male. (2003)
  65. ^ Srinivasan M, et al. Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J Clin Endocrinol Metab. (2010)
  66. ^ Boxer RS, et al. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing. (2010)
  67. ^ Kiechl S, et al. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler Thromb Vasc Biol. (2000)
  68. ^ Omura Y, et al. Bi-directional transmission of molecular information by photon or electron beams passing in the close vicinity of specific molecules, and its clinical and basic research applications: 1) Diagnosis of humans or animal patients without any direct contact; 2) Light microscopic and electron microscopic localization of neuro-transmitters, heavy metals, Oncogen C-fos (AB2), etc. of intracellular fine structures of normal and abnormal single cells using light or electro-microscopic indirect Bi-Digital O-Ring Test. Acupunct Electrother Res. (1992)
  69. ^ Omura Y. Electro-magnetic resonance phenomenon as a possible mechanism related to the “bi-digital o-ring test molecular identification and localization method”. Acupunct Electrother Res. (1986)
  70. ^ a b c d e Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA. (2004)
  71. ^ a b c d Genazzani AD, et al. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril. (2003)
  72. ^ Talaei A, et al. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose tolerance. Hormones (Athens). (2010)
  73. ^ a b c Lasco A, et al. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol. (2001)
  74. ^ a b Casson PR, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril. (1995)
  75. ^ a b c d e Diamond P, et al. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol. (1996)
  76. ^ a b c d Kawano H, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab. (2003)
  77. ^ a b c d e Nestler JE, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. (1988)
  78. ^ a b c d Panjari M, et al. The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas. (2009)
  79. ^ a b c d e Morales AJ, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. (1994)
  80. ^ a b c Igwebuike A, et al. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab. (2008)
  81. ^ a b c Basu R, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes. (2007)
  82. ^ a b c Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. (1990)
  83. ^ Brown GA, et al. Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J Appl Physiol. (1999)
  84. ^ Liao YH, et al. Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage. Eur J Appl Physiol. (2012)
  85. ^ Ostojic SM, Calleja J, Jourkesh M. Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletes. Chin J Physiol. (2010)
  86. ^ Vogiatzi MG, et al. Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance. Metabolism. (1996)
  87. ^ Yamada Y, et al. Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons. Endocr J. (2007)
  88. ^ a b Taniguchi S, et al. The antiobesity effect of dehydroepiandrosterone in castrated or noncastrated obese Zucker male rats. Obes Res. (1995)
  89. ^ a b Kajita K, et al. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. Endocrinology. (2003)
  90. ^ Richards RJ, Porter JR, Svec F. Long-term oral administration of dehydroepiandrosterone has different effects on energy intake of young lean and obese male Zucker rats when compared to controls of similar metabolic body size. Diabetes Obes Metab. (1999)
  91. ^ Abadie JM, et al. Dehydroepiandrosterone alters Zucker rat soleus and cardiac muscle lipid profiles. Exp Biol Med (Maywood). (2001)
  92. ^ Pham J, et al. The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiol Behav. (2000)
  93. ^ Pasiakos SM, et al. Appetite and endocrine regulators of energy balance after 2 days of energy restriction: insulin, leptin, ghrelin, and DHEA-S. Obesity (Silver Spring). (2011)
  94. ^ Ryu JW, et al. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem Biophys Res Commun. (2003)
  95. ^ a b de Heredia FP, et al. Effect of dehydroepiandrosterone on protein and fat digestibility, body protein and muscular composition in high-fat-diet-fed old rats. Br J Nutr. (2007)
  96. ^ Alberg AJ, et al. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. (2000)
  97. ^ Yoshida S, et al. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Steroids. (2003)
  98. ^ Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women.
  99. ^ a b c d Morales AJ, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). (1998)
  100. ^ a b c Libè R, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest. (2004)
  101. ^ Kritz-Silverstein D, et al. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc. (2008)
  102. ^ Dayal M, et al. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. J Womens Health (Larchmt). (2005)
  103. ^ a b c d Genazzani AR, et al. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. Aging Male. (2004)
  104. ^ Bernardi F, et al. Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril. (2005)
  105. ^ a b c Hunt PJ, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trial. J Clin Endocrinol Metab. (2000)
  106. ^ a b Arlt W, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. (1999)
  107. ^ Abrams DI, et al. Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. AIDS Res Hum Retroviruses. (2007)
  108. ^ Eylert MF, Persad R. Management of prostate cancer. Br J Hosp Med (Lond). (2012)
  109. ^ Weiss EP, et al. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY). (2011)
  110. ^ a b Sun Y, et al. Treatment of osteoporosis in men using dehydroepiandrosterone sulfate. Chin Med J (Engl). (2002)
  111. ^ a b Morales A, et al. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. Aging Male. (2009)
  112. ^ Reiter WJ, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology. (1999)
  113. ^ Arnold JT, et al. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab. (2005)
  114. ^ Rhoden EL, et al. Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats. J Urol. (2003)
  115. ^ a b Brooke AM, et al. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement. Clin Endocrinol (Oxf). (2006)
  116. ^ a b Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults.
  117. ^ a b Percheron G, et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med. (2003)
  118. ^ Welle S, Jozefowicz R, Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. (1990)
  119. ^ a b Wolf OT, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab. (1997)
  120. ^ a b c d e Nair KS, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. (2006)
  121. ^ a b c d Baulieu EE, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. (2000)
  122. ^ a b Felt V, Stárka L. Metabolic effects of dehydroepiandrosterone and Atromid in patients with hyperlipaemia. Cor Vasa. (1966)
  123. ^ Flynn MA, et al. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab. (1999)
  124. ^ a b Wolkowitz OM, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. (1997)
  125. ^ a b Jankowski CM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab. (2006)
  126. ^ Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci. (1997)
  127. ^ Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci. (1995)
  128. ^ a b Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial.
  129. ^ van Thiel SW, et al. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab. (2005)
  130. ^ Koó E, et al. Effect of dehydroepiandrosterone on hereditary angioedema. Klin Wochenschr. (1983)
  131. ^ a b Callies F, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab. (2001)
  132. ^ Abrahamsson L, Hackl H. Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot or dehydroepiandrosterone (DHEA) oenanthate. Maturitas. (1981)
  133. ^ Genazzani AD, et al. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertil Steril. (2001)
  134. ^ Casson PR, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril. (1998)
  135. ^ Løvås K, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab. (2003)
  136. ^ Calvo E, et al. Pangenomic changes induced by DHEA in the skin of postmenopausal women. J Steroid Biochem Mol Biol. (2008)
  137. ^ Williams MR, et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab. (2004)
  138. ^ a b Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf). (2000)
  139. ^ Hackbert L, Heiman JR. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med. (2002)
  140. ^ Stomati M, et al. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Gynecol Endocrinol. (2000)
  141. ^ Barton DL, et al. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. (2006)
  142. ^ Johannsson G, et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab. (2002)
  143. ^ Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison’s disease.
  144. ^ Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes. (2005)
  145. ^ Gordon CM, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. (2002)
  146. ^ Brooke AM, et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab. (2006)
  147. ^ Bilger M, et al. Androgen replacement in adolescents and young women with hypopituitarism. J Pediatr Endocrinol Metab. (2005)
  148. ^ van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. (1994)
  149. ^ Petri MA, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. (2004)
  150. ^ Chang DM, et al. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. (2002)
  151. ^ Barry NN, McGuire JL, van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. J Rheumatol. (1998)
  152. ^ Nordmark G, et al. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity. (2005)
  153. ^ Petri MA, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. (2002)
  154. ^ van Vollenhoven RF, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus. (1999)
  155. ^ Schubert K, Wehrberger K, Hobe G. Androsta-3,5-diene-7,17-dione: isolation from urine and formation from 7-keto-dehydro-epiandrosterone sulphate under various conditions of hydrolysis. Endocrinol Exp. (1971)
  156. ^ Marwah A, Marwah P, Lardy H. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. J Chromatogr B Analyt Technol Biomed Life Sci. (2002)
  157. ^ a b Numazawa M, et al. Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromatase. J Med Chem. (1994)
  158. ^ Muller M, et al. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. J Clin Endocrinol Metab. (2006)
  159. ^ Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue.
  160. Yamada S, et al. Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr Gerontol Int. (2010)
  161. von Mühlen D, et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int. (2008)
  162. Ma H, et al. Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report. BMC Complement Altern Med. (2011)
  163. Parsons TD, et al. Dhea supplementation and cognition in postmenopausal women. Int J Neurosci. (2006)
  164. Wallace MB, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. (1999)
  165. Kenny AM, et al. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc. (2010)
  166. Genazzani AR, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol. (2006)
  167. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod. (2006)
  168. Taylor MK, et al. Effects of dehydroepiandrosterone supplementation during stressful military training: a randomized, controlled, double-blind field study. Stress. (2012)
  169. Wiser A, et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod. (2010)
  170. Kahn AJ, et al. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab. (2002)
  171. Weiss EP, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. (2009)